Search Results - "Hong, Simon"

Frailty, Thy Diagnosis Is Uncertain: Impact on IBD Readmission and Mortality by Hong, Simon J., Katz, Seymour

Get full text

Ustekinumab and Vedolizumab Are Not Associated With Subsequent Cancer in IBD Patients with Prior Malignancy by Hong, Simon J, Zenger, Cameron, Pecoriello, Jillian, Pang, Alice, Vallely, Margaret, Hudesman, David P, Chang, Shannon, Axelrad, Jordan E

“…There is little data regarding the risk of new or recurrent cancer in patients with inflammatory bowel disease (IBD) and a prior history of cancer who are…”
Get full text

Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates by Hong, Simon, Jhou, Thomas C, Smith, Mitchell, Saleem, Kadharbatcha S, Hikosaka, Okihide

“…Lateral habenula (LHb) neurons signal negative "reward-prediction errors" and inhibit midbrain dopamine (DA) neurons. Yet LHb neurons are largely…”
Get full text

A Joint Effort: Improving the Identification of Spondyloarthritis in Patients With Inflammatory Bowel Disease by Hong, Simon J, Hudesman, David P, Scher, Jose U

Get full text

The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management by Hong, Simon J., Katz, Seymour

“…The incidence and prevalence of inflammatory bowel disease (IBD) is rising in the elderly population. Compared with patients with onset during their younger…”
Get full text

Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection by Feuerstadt, Paul, Hong, Simon J., Brandt, Lawrence J.

“…Background and Aim Rifaximin is an antimicrobial which is used for prophylaxis of hepatic encephalopathy in patients with cirrhosis and has known anti-…”
Get full text

Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience by Malter, Lisa, Hong, Simon J, Lopatin, Sarah, Murphy, Megan, Hudesman, David, Kane, Sunanda, Rubin, David T

“…Inflammatory bowel disease (IBD) management has become increasingly complex, and education varies across fellowship programs. IBD 101 was designed to introduce…”
Get full text

Long-term dopamine neurochemical monitoring in primates by Schwerdt, Helen N., Shimazu, Hideki, Amemori, Ken-ichi, Amemori, Satoko, Tierney, Patrick L., Gibson, Daniel J., Hong, Simon, Yoshida, Tomoko, Langer, Robert, Cima, Michael J., Graybiel, Ann M.

“…Many debilitating neuropsychiatric and neurodegenerative disorders are characterized by dopamine neurotransmitter dysregulation. Monitoring subsecond dopamine…”
Get full text

A pallidus-habenula-dopamine pathway signals inferred stimulus values by Bromberg-Martin, Ethan S, Matsumoto, Masayuki, Hong, Simon, Hikosaka, Okihide

“…The reward value of a stimulus can be learned through two distinct mechanisms: reinforcement learning through repeated stimulus-reward pairings and abstract…”
Get full text

S961 Risk of New or Recurrent Cancer After Vedolizumab or Ustekinumab Exposure in Patients With Inflammatory Bowel Disease and Previous Cancer by Zenger, Cameron, Hong, Simon J., Pecoriello, Jillian, Pang, Alice S., Vallely, Margaret, Hudesman, David, Chang, Shannon, Axelrad, Jordan

Get full text

S859 Defining the Disease Characteristics of Concurrent Inflammatory Bowel Disease and Psoriasis or Psoriatic Arthritis by Rabbenou, Wendy, Jaros, Brian, Chang, Shannon, Axelrad, Jordan, Scher, Jose, Hudesman, David, Haberman, Rebecca, Hong, Simon J.

Get full text

MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection by Hong, Simon J., Feuerstadt, Paul, Brandt, Lawrence J.

“…Clostridium difficile infection (CDI) is the most common nosocomial infection in the US and cirrhotic patients with CDI have increased risk for poor outcome…”
Get full text

Predominant Striatal Input to the Lateral Habenula in Macaques Comes from Striosomes by Hong, Simon, Amemori, Satoko, Chung, Emily, Gibson, Daniel J., Amemori, Ken-ichi, Graybiel, Ann M.

“…Striosomes, neurochemically specialized modules in the striatum, are thought to be nodes in circuits extending, via basal ganglia pathways, from mood-related…”
Get full text

Diverse sources of reward value signals in the basal ganglia nuclei transmitted to the lateral habenula in the monkey by Hong, Simon, Hikosaka, Okihide

“…The lateral habenula (LHb) plays an important role in motivational decision making. Neurons in the primate LHb signal negative 'reward prediction errors' and…”
Get full text

S1132 Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults With Inflammatory Bowel Disease by Sachar, Moniyka, Fernandez, Cristina, Beaty, William, Rojanasopondist, Pakdee, Delau, Olivia, Li, Alice, Murphy, Megan, Axelrad, Jordan, Hong, Simon J., Holmer, Ariela, Chang, Shannon, Hudesman, David, Katz, Seymour, Malter, Lisa, Faye, Adam S.

“…In multivariate analysis, measures of disease severity (prior biologic use, prior steroid use, severe baseline disease) but not age, were associated with…”
Get full text

New insights on the subcortical representation of reward by Hikosaka, Okihide, Bromberg-Martin, Ethan, Hong, Simon, Matsumoto, Masayuki

“…Reward information is represented by many subcortical areas and neuron types, which constitute a complex network. Its output is usually mediated by the basal…”
Get full text

Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes by Hong, Simon J., Jang, Janice, Berg, Dana, Kirat, Tarik, Remzi, Feza, Chang, Shannon, Malter, Lisa B., Axelrad, Jordan E., Hudesman, David P.

“…Background There is wide variation in the quality of care of hospitalized patients with inflammatory bowel disease (IBD). Prior studies have demonstrated that…”
Get full text

Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease by Stone, Katherine L., Kulekofsky, Emma, Hudesman, David, Kozloff, Samuel, Remzi, Feza, Axelrad, Jordan E., Katz, Seymour, Hong, Simon J., Holmer, Ariela, McAdams-DeMarco, Mara A., Segev, Dorry L., Dodson, John, Shaukat, Aasma, Faye, Adam S.

“…Background: The COVID-19 pandemic led to the urgent implementation of telehealth visits in inflammatory bowel disease (IBD) care; however, data assessing…”
Get full text

S697 Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease with Active or Recent Malignancy: A Multi-Center Cohort Study by Holmer, Ariela K., Luo, Jiyu, Park, Sarah, Yang, Jeong Yun, Nguyen, Vu Q., Sofia, M. Anthony, Ertem, Furkan, Dueker, Jeffrey M., Petrov, Jessica C., Al Bawardy, Badr F., Llano, Ernesto M., Fudman, David, Joseph, Dailey, Jangi, Sushrut, Russ, Kirk, Khakoo, Nidah S., Damas, Oriana, Barnes, Edward L., Hong, Simon J., Zenger, Cameron, Axelrad, Jordan, Scott, Frank I., MSCE, Ungaro, Ryan, Singh, Siddharth

Get full text

Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States by Hong, Simon J, Krugliak Cleveland, Noa, Akiyama, Shintaro, Zullow, Samantha, Yi, Yangtian, Shaffer, Seth R, Malter, Lisa B, Axelrad, Jordan E, Chang, Shannon, Hudesman, David P, Rubin, David T

“…Ustekinumab has been recently approved for the treatment of moderately to severely active ulcerative colitis (UC). The registry trials for ustekinumab in UC…”
Get full text